Loading…

Loading grant details…

Active HORIZON European Commission

EuroPean Training NetwoRks to TArget DAMPs and NETs: novel apprOaches in pRecision SepsIs pAtieNt care


Funder European Commission
Recipient Organization Universiteit Maastricht
Country Netherlands
Start Date Jan 01, 2024
End Date Dec 31, 2027
Duration 1,460 days
Number of Grantees 18
Roles Associated Partner; Participant; Coordinator
Data Source European Commission
Grant ID 101119819
Grant Description

Sepsis remains one of the major challenges for societies worldwide, causing an estimated 7-9 million deaths every year. It is the leading cause of death at intensive care units in the EU.

This high mortality persists because at present methods for timely diagnosis are lacking and no effective therapy is available. Therefore, there is a clear and urgent medical need to provide novel diagnostics and therapeutics for use in sepsis.

The PRAETORIAN Doctoral Network has created a doctorate programme to deliver innovative training on preclinical and clinical science, business- and entrepreneurial aspects, intellectual properties and more, covering multiple aspects of the drug discovery and development process.

This programme is unique as it will deliver a new generation of young scientists, each Doctoral Candidates (DCs), who will collaboratively work to develop novel approaches in precision sepsis patient care providing new diagnostics and therapeutics to answer to an urgent unmet clinical need.

Recent insights have indicated a pivotal role for neutrophil activation and so-called damage associated patterns in the initiation and propagation of sepsis.

However a comprehensive view on how these processes cause the onset of sepsis remains elusive and there is an urgent need to translate experimental findings into adequate diagnostic and therapeutic solutions.

PRAETORIAN was designed to address this urgent need by bringing together specialists from academia and industry to shape a new generation of entrepreneurial scientists who have skills, expertise and knowhow to further our understanding of sepsis pathophysiology into tangible and effective solutions for novel diagnosis and therapy.

All Grantees

Bergenbio As; Sepsisföreningen; Universitaet Muenster; Biosynth Bv; 5-Diagnostics Ltd; Double Green Pharma; Uppsala Universitet; Universiteit Maastricht; Agencia Estatal Consejo Superior de Investigaciones Cientificas; Hopital Erasme - Cliniques Universitaires de Bruxelles; France Sepsis Association; Maastricht Health Campus Bv; Nsbm; Universite Paris Cite; Deutsche Sepsis-Gesellschaft E.V.; Pharmatarget Bv; Stichting Family and Patient Centered Intensive Care (Fcic); Basic Pharma Technologies B.V.

Advertisement
Apply for grants with GrantFunds
Advertisement
Browse Grants on GrantFunds
Interested in applying for this grant?

Complete our application form to express your interest and we'll guide you through the process.

Apply for This Grant